Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 6/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | CTSS | P25774 | 1/20 | 0.46 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL236526 | 0.98 | KMT2A (0.58) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL6249941 | 0.98 | KMT2A (0.58) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL6249937 | 0.98 | KMT2A (0.58) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL236527 | 0.98 | KMT2A (0.58) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL3340721 | 0.97 | KMT2A (0.57) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL3340707 | 0.97 | KMT2A (0.57) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| Phenylacetic Acid SCHEMBL6567966 | 0.94 | KMT2A (0.54) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL31499163 | 0.94 | NAALAD2 (0.58) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| Glycine SCHEMBL28484996 | 0.93 | KMT2A (0.53) | KMT2ACNR2NAALAD2MMP2MMP9 | |
| SCHEMBL20302075 | 0.90 | KMT2A (0.50) | KMT2ACNR2NAALAD2MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238230-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE | 2024-07-18 | — | — | US | disclosed |
| US-11786494-B2 | Methods of modulation of branched chain acids and uses thereof | BAYLOR COLLEGE OF MEDICINE (US) | 2023-10-17 | — | — | US | disclosed |
| US-20200147016-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | ACER THERAPEUTICS INC. | 2020-05-14 | — | — | US | disclosed |
| US-20190151268-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | ACER THERAPEUTICS INC. | 2019-05-23 | — | — | US | disclosed |
| US-10092532-B2 | Methods of modulation of branched chain acids and uses thereof | BAYLOR COLLEGE OF MEDICINE (US) | 2018-10-09 | — | — | US | disclosed |
| US-20170312238-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | ACER THERAPEUTICS INC. | 2017-11-02 | — | — | US | disclosed |
| US-9737499-B2 | Methods of modulation of branched chain acids and uses thereof | BAYLOR COLLEGE OF MEDICINE (US) | 2017-08-22 | — | — | US | disclosed |
| EP-3100610-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | Baylor College Of Medicine (US) | 2016-12-07 | — | — | EP | disclosed |
| US-20150359765-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE (US) | 2015-12-17 | — | — | US | disclosed |
| EP-2954780-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | Baylor College Of Medicine (US) | 2015-12-16 | — | — | EP | disclosed |
| EP-2456304-B1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE MEDICINE (US) | 2015-08-19 | — | — | EP | disclosed |
| US-9078865-B2 | Methods of modulation of branched chain acids and uses thereof | BAYLOR COLLEGE OF MEDICINE (US) | 2015-07-14 | — | — | US | disclosed |
| US-20120220661-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE (US) | 2012-08-30 | — | — | US | disclosed |
| EP-2456304-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | Baylor College Of Medicine (US) | 2012-05-30 | — | — | EP | disclosed |
| WO-2011011781-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE (US) | 2011-01-27 | — | — | WO | disclosed |
| US-4284647-A | ADMINISTERING BENZOIC OR PHENYLACETIC ACID | THE JOHNS HOPKINS UNIVERSITY (US) | 1981-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190151268-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-20240238230-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-10092532-B2 | Methods of modulation of branched chain acids and uses thereof | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-20120220661-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-20170312238-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-20150359765-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-20200147016-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
| US-11786494-B2 | Methods of modulation of branched chain acids and uses thereof | OAT, ABAT, BCKDK | KMT2A 2786/4885CNR2 4489/4885NAALAD2 1440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.